The Pontifical Academy for Life has published an updated document in which it considers the use of animal-origin organs in human transplants to be ethically acceptable, in response to recent scientific advances in this field.
According to AICA, the text—titled “Perspectives on Xenotransplantation”—reviews the document published in 2001 and incorporates progress in genetic engineering and the first positive results in clinical trials with pig organs.
No Religious Impediments to Xenotransplantation
The Vatican body states that “Catholic theology presents no impediments” to the use of animals as a source of organs, tissues, or cells intended to save human lives.
In this regard, it holds that the sacrifice of animals can be considered legitimate when there is a significant benefit for human beings, even if it involves experimentation or genetic modification.
Ethical Conditions and Limits on the Use of Animals
The Academy emphasizes that these practices must be developed under clear ethical criteria, avoiding unnecessary suffering of animals and respecting biodiversity.
Additionally, it insists that human intervention in nature must be “intentional, proportionate, and sustainable,” within the framework of man’s responsibility toward creation.
Patient Identity and Bioethical Issues
The document also addresses concerns about possible hybrids between species, assuring that xenotransplants do not alter the recipient’s genetic or biological identity.
From this perspective, the use of animal organs—including those from genetically modified pigs—does not pose a threat to the patient’s personal or spiritual identity.
Likewise, it considers research on individuals with brain death as a legitimate step prior to clinical trials, although it calls for further deepening in its ethical evaluation.
Informed Consent and Health Equity
The text places special emphasis on the need for rigorous informed consent, warning of risks such as the possible transmission of animal infections and the need for lifelong medical follow-up.
It also states that the development of these techniques must not compromise equity in access to health resources.